Building upon this, the incorporation of a triple therapy regimen comprising radiotherapy, anti-PD-1, and anti-TIGIT has presented promising results in various tumor-bearing models, despite the fact that optimizing the radiotherapy strategy required careful consideration to ensure its effectiveness. This evidence concerns the gene TIGIT and neoplasm.